Clinical research 101: Why should you care?
- First Online:
- Cite this article as:
- Stead, L.G. & Decker, W.W. Int J Emerg Med (2008) 1: 121. doi:10.1007/s12245-008-0035-1
- 515 Views
Let’s look at a few examples:
Unable to bear weight immediately and in ED?
Tender on the lateral malleolar tip or posterior aspect of the lateral malleolus?
Tender on the medial malleolar tip or posterior aspect of the medial malleolus?
Most practicing emergency medicine clinicians will recognize these as the questions used for the Ottawa ankle rule . This was a prospective survey administered in two stages: derivation and refinement of the original rules (first stage) and validation of the refined rules (second stage). The cohort consisted of a convenience sample of adults with acute ankle injuries: 1,032 of 1,130 eligible patients in the first stage and 453 of 530 eligible patients in the second stage. While these research method details may seem not useful to daily clinical practice, the results derived from this study certainly are.
No posterior midline cervical-spine tenderness
No evidence of intoxication
A normal level of alertness
No focal neurologic deficit
No painful distracting injuries
The above represent the NEXUS low risk criteria, which state that if a patent has all of the above, then they do not require cervical spine radiography . This prospective observational study was conducted across 21 centers in the US. The study population consisted of 34,069 patients evaluated by imaging of the cervical spine after blunt trauma. Of these, 2.4% had radiographically documented cervical-spine injury. These results yielded an overall sensitivity of 99%, specificity of 12.9%, and a negative predictive value of 99.8%. Again, while conducting such a study may not appeal to everyone, the results from such investigations do impact everyday patient care.
A 45-year-old male presents to the ED with chest pain of 2.5-h duration, radiating to the left arm, associated with diaphoresis, relieved by sublingual nitroglycerin in the ambulance, and rated 5/10. Family history is unknown.
What blood test will you order?
855 patients with symptoms of acute myocardial ischemia within 12 h of onset had serum troponin T, CK-MB, and ECG done and analyzed in blinded fashion. Logistic regression was used to assess the usefulness of baseline levels of troponin T and CK-MB vs. ECG findings (ST-segment elevation, ST-segment depression, T-wave inversion, or the presence of confounding factors that impair the detection of ischemia). On admission, 289 of 801 patients with base-line serum samples had elevated troponin T. Mortality within 30 days was significantly higher in these patients than in patients with lower levels of troponin T (11.8% vs. 3.9%, P < 0.001). Troponin T levels remained significantly predictive of 30-day mortality in a model that contained ECG categories and CK-MB levels (chi-square = 9.2, P = 0.027). The authors of the study concluded that cardiac troponin T level is a powerful, independent risk marker in patients who present with acute myocardial infarction.
Today, most clinicians routinely use this serum marker, perhaps not thinking about its origins from a research study.
So, why care about clinical research?
“The real voyage of discovery consists not in seeking new landscapes, but in having new eyes.”